phentermine-topiramate and glp-1 receptor agonists abbvie agonist weight management diabetes treatments What's New in Obesity Treatment? Ozempic vs. Phentermine: Side Effects

A limited exception to market exclusivity exists for drugs on the FDAs shortage list, which indicates a drug in low supply

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

Clinically backed oral GLP-1 support with a 321% natural GLP-1 boost

Allulose is not a GLP-1 agonist, but emerging research suggests it may modulate glucose metabolism and GLP-1 secretion in ways that merit clinical attention

This supports that pharmacies are permitted to compound GLP-1 drugs under section 503A of the Act, provided they adhere to specific conditions outlined by the FDA

The study published in JAMA Psychiatry found that patients with alcohol use disorder (AUD) who were prescribed GLP-1 drugs, popularly known by their brand names Ozempic and Wegovy, had a significantly lower risk of hospitalization for alcohol-related issues.Background on Semaglutide and LiraglutideSemaglutide and liraglutide are medications b